£795.00

The 2023-2028 World Outlook for Genome Editing-Genome Engineering

Subjects

Price data last checked 18 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£795 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 73 days · 73 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 73 days • 1 price levels

Days at Price

Price Analysis

Most common price: £795 (73 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 73 days

Description

This study covers the world outlook for genome editing-genome engineering across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of genome editing-genome engineering as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include CRISPR Therapeutics, Editas Medicine, GenScript Biotech, Horizon Discovery Group, Integrated DNA Technologies, Lonza Group, Merck & Company, New England Biolabs, OriGene Technologies, Sangamo Therapeutics, Thermo Fisher Scientific, and Transposagen Biopharmaceuticals. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format: paperback
ASIN: B09YQW88PK
Category: Books > Subjects
Domain: Amazon UK
Release Date: 10 May 2022
Listed Since: 07 May 2022

The 2023-2028 World Outlook for Genome Editing-Genome Engineering

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2021-2026 World Outlook for Genome Editing

The 2025-2030 World Outlook for Genome Editing-Genome Engineering

The 2025-2030 World Outlook for Genome Editing

The 2023 Report on Genome Editing-Genome Engineering: World Market Segmentation by City

The 2025-2030 World Outlook for Gene Editing Tools

The 2023 Report on Gene Editing Tools: World Market Segmentation by City

The 2023-2028 World Outlook for Genomics and Proteomics Reagents, Research Kits and Analytical Instruments

The 2023-2028 Outlook for Consumer Genomics in China

The 2023-2028 Outlook for Genetic Modification Therapies in China

The 2025-2030 World Outlook for Genetic Modification Therapies

The 2023-2028 World Outlook for Genomics in Cancer Care

The 2016-2021 Outlook for Gene Expression Services in Japan

The 2016-2021 Outlook for Epigenetic Technologies in Greater China

Genome Editing - Recent Advances and Applications (Genetics)

The 2023-2028 World Outlook for CRISPR Genome Editing and Genome Engineering

The 2016-2021 Outlook for Epigenetic Technologies in Japan

The 2025-2030 World Outlook for Genomics and Proteomics Sample Preparation Kits

Humana Genome Editing in Animals: Methods and Protocols 2637

The 2013-2018 Outlook for Epigenetic Technologies in India

Genome Editing in Biomedical Sciences: 1429 (Advances in Experimental Medicine and Biology, 1429)

The 2025-2030 World Outlook for Genomics and Proteomics Reagents, Research Kits and Analytical Instruments

The 2025-2030 World Outlook for Medical Gene Amplification Technologies

The 2023-2028 World Outlook for Genetic Testing

The 2023-2028 World Outlook for Genetic Testing Services